Jane Street’s Cymabay Therapeutics CBAY Stock Holding History

Jane Street’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-102,700	Closed	-$2.43M	–	10346
2023 Q4	$2.43M	Sell	102,700 -244,700	-70%	-$4.36M	﹤0.01%	3994
2023 Q3	$5.18M	Buy	+347,400	New	+$4.61M	﹤0.01%	2555
2023 Q2	–	Sell	-52,000	Closed	-$453K	–	9820
2023 Q1	$453K	Buy	+52,000	New	+$416K	﹤0.01%	6485
2021 Q1	–	Sell	-40,700	Closed	-$234K	–	9718
2020 Q4	$234K	Buy	40,700 +7,600	+23%	+$57.5K	﹤0.01%	6759
2020 Q3	$240K	Buy	+33,100	New	+$177K	﹤0.01%	6191

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's CBAY Position: Q1 2024 in Review

Jane Street sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 194,968 shares — an estimated $4.61M sold.

Jane Street first reported a position in CBAY in Q1 2019 and held it in 13 quarters. The position peaked at $4.98M in Q1 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Jane Street reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Jane Street sold 194,968 Cymabay Therapeutics shares in Q1 2024, an estimated $4.61M.
Jane Street first reported a position in Cymabay Therapeutics in Q1 2019 and held it in 13 quarters.
Jane Street's Cymabay Therapeutics position peaked at $4.98M in Q1 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.